Ask AI

Optimizing Multidisciplinary Care in Extensive-Stage SCLC

Slideset

Released: September 15, 2026

See Activity Collection

Downloadable slides on the current and evolving treatment paradigm in extensive-stage small-cell lung cancer (SCLC), optimal approaches for the selection of first-line therapy for individual patients (including veterans), novel and emerging targeted therapies, ways to navigate the selection of optimal treatment options for patients with relapsed extensive-stage SCLC, agents targeting DLL3 in neuroendocrine cancers, key agents and combinations under investigation in extensive-stage SCLC, safety and management of treatment-associated adverse events, key ongoing phase III trials in extensive-stage SCLC, and multidisciplinary strategies to support equitable care for all patients.

Extensive Stage SCLC

Activity Information

Released: September 15, 2026